腔内血栓与急性大血管闭塞性卒中血管内治疗结局
基于全国前瞻性登记研究,纳入711例24小时内接受血管内治疗的急性大血管闭塞性卒中患者,术前DSA评估腔内血栓(ILT)。75例(10.5%)存在ILT,其90天功能依赖(mRS 3-6)风险更低(aOR 0.53, 95%CI 0.31-0.90, P=0.021),24小时大血管闭塞率更低(aOR 0.34, 95%CI 0.13-0.89, P=0.028),但症状性颅内出血和90天死亡风险相似。
要点
- 术前DSA发现ILT的急性LVO患者,90天功能依赖风险更低。
- ILT与24小时大血管闭塞率降低独立相关。
- ILT患者症状性颅内出血和90天死亡风险与无ILT者相似。
核心结论
- 急性LVO血管内治疗患者中,术前ILT阳性者90天功能结局可能更好,但死亡和症状性颅内出血风险相似。
- ILT的可能有利效应在成功再灌注患者中持续存在。
研究设计与样本
- 前瞻性全国登记研究,纳入24小时内接受血管内治疗的急性LVO卒中患者711例。
- 术前DSA评估ILT存在情况,比较ILT阳性与阴性患者的结局。
主要发现
- 711例中75例(10.5%)存在ILT。
- ILT阳性者90天功能依赖(mRS 3-6)调整OR 0.53(95%CI 0.31-0.90),P=0.021。
- 成功再灌注(mTICI 2b-3)亚组中ILT与更好结局相关(P=0.008),未成功再灌注亚组无此关联(P=0.107)。
- ILT与24小时LVO降低独立相关,调整OR 0.34(95%CI 0.13-0.89),P=0.028。
- ILT阳性与阴性者症状性颅内出血和90天死亡风险相似。
关键数值与推荐
- 主要结局为90天功能依赖(mRS 3-6)。
- 次要结局包括24小时LVO、90天死亡和症状性颅内出血。
临床怎么用
- 术前DSA发现ILT可能提示血管内治疗后功能结局较好,可辅助预后评估。
- ILT患者仍需关注死亡和症状性颅内出血风险,与无ILT者相似。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Intraluminal thrombus (ILT) is an emerging imaging marker in acute ischemic stroke. We aimed to investigate the association of ILT with outcomes of acute large vessel occlusion (LVO) patients receiving endovascular treatment. METHODS: Acute LVO stroke patients who underwent endovascular treatment within 24 hours, in a prospective, nationwide registry were enrolled. Pretreatment digital subtraction angiography was reviewed for the presence of ILT. The primary outcome was 90-day functional dependence (modified Rankin Scale scores, 3-6). Secondary outcomes included 24-hour LVO, 90-day death, and symptomatic intracranial hemorrhage. RESULTS: Among 711 patients enrolled, 75 (10.5%) with ILT were less likely to have 90-day functional dependence compared with those without ILT (adjusted odds ratio, 0.53 [95% CI, 0.31-0.90]; P=0.021). The same trend was found among those with successful reperfusion (modified Thrombolysis in Cerebral Infarction 2b-3; P=0.008) but not in those without successful reperfusion (P=0.107). Presence of ILT was also independently associated with a lower rate of 24-hour LVO (adjusted odds ratio 0.34 [95% CI, 0.13-0.89]; P=0.028). However, those with or without ILT had similar risks of symptomatic intracranial hemorrhage and 90-day death. CONCLUSIONS: Among acute LVO patients receiving endovascular treatment, pretreatment ILT-positive patients may have a better 90-day functional outcome (versus ILT-negative) but similar risk of death and symptomatic intracranial hemorrhage. The possibly favorable effect of ILT patients remained in those with successful reperfusion. Registration: URL: http://www.chictr.org.cn; Unique identifier: ChiCTR1900022154.
引用
- Ding Y, Leng X, Nie X, et al. Intraluminal Thrombus and Outcomes of Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Treatment. Stroke. 2021. PMID: 33657858. doi:10.1161/STROKEAHA.120.032876
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。